Long term rehabilitation is often required for patients who have suffered traumatic and ischemic brain injury. The requirement for long-term rehabilitation is directly determined by the extent of permanent neuron loss. Since neuron loss occurs during a delayed as well as an acute phase, one approach to improving the outcome in such patients is to develop therapies that limit delayed neuron destruction. We propose the development of a herpes virus based gene therapy approach in which the expression of neuroprotective proteins in the peri-injury period will reduce the extent of neuron death and limit the loss of function of surviving neurons. Specifically, we will test the efficacy of gene transfer and expression of neurotrophic factors in an in vivo model of traumatic injury, and the gene for bcl2 in an organotypic hippocampal slice culture system and an in vivo model of ischemic injury. A role for neurotrophic factors in the maintenance of neuron function in experimental traumatic injury has been previously suggested. We hypothesize that delayed neuron loss following ischemic injury to the hippocampal formation to be a form of apoptosis. For this reason, we will transfer the gene for bcl2, because its expression has been shown to be neuroprotective in other apoptotic models.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD031300-05
Application #
2673743
Study Section
Neurology C Study Section (NEUC)
Project Start
1994-07-01
Project End
1999-06-30
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Rochester
Department
Neurology
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
DeCory, H H; Piech-Dumas, K M; Sheu, S S et al. (2001) Efflux of glutathione conjugate of monochlorobimane from striatal and cortical neurons. Drug Metab Dispos 29:1256-62
Karpoff, H M; Kooby, D; D'Angelica, M et al. (2000) Efficient cotransduction of tumors by multiple herpes simplex vectors: implications for tumor vaccine production. Cancer Gene Ther 7:581-8
Ding, D; Moskowitz, S I; Li, R et al. (2000) Acidosis induces necrosis and apoptosis of cultured hippocampal neurons. Exp Neurol 162:12-Jan
Telfeian, A E; Federoff, H J; Leone, P et al. (2000) Overexpression of GluR6 in rat hippocampus produces seizures and spontaneous nonsynaptic bursting in vitro. Neurobiol Dis 7:362-74
Halterman, M W; Miller, C C; Federoff, H J (1999) Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci 19:6818-24
Brooks, A I; Halterman, M W; Chadwick, C A et al. (1998) Reproducible and efficient murine CNS gene delivery using a microprocessor-controlled injector. J Neurosci Methods 80:137-47
Federoff, H J; Brooks, A; Muhkerjee, B et al. (1997) Somatic gene transfer approaches to manipulate neural networks. J Neurosci Methods 71:133-42
Brooks, A I; Muhkerjee, B; Panahian, N et al. (1997) Nerve growth factor somatic mosaicism produced by herpes virus-directed expression of cre recombinase. Nat Biotechnol 15:57-62
Geschwind, M D; Hartnick, C J; Liu, W et al. (1996) Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: model for treatment of neuron loss following cochlear degeneration. Hum Gene Ther 7:173-82
Linnik, M D; Zahos, P; Geschwind, M D et al. (1995) Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 26:1670-4;discussion 1675

Showing the most recent 10 out of 11 publications